Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cholangiocarcinomas”

1,024 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,024 results

Large-scale testing (Phase 3)UnknownNCT02773485
What this trial is testing

Chemo Alone or in Combination With Radiation in Unresectable Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Tata Memorial Hospital 155
Not applicableUnknownNCT04846192
What this trial is testing

Prognosis of Nutritional Status for Surgical Peri Hilar Cholangiocarcinoma

Who this might be right for
Perihilar Cholangiocarcinoma
Central Hospital, Nancy, France 40
Large-scale testing (Phase 3)UnknownNCT00653978
What this trial is testing

Unilateral Versus Bilateral Stents for Bismuth Type II and III Malignant Hilar Strictures

Who this might be right for
Cholangiocarcinoma
Changhai Hospital 150
Not applicableStudy completedNCT01773655
What this trial is testing

Clinical and Histopathologic Characteristics of BAP1 Mutations

Who this might be right for
Malignant Pleural Mesothelioma (MPM)Choroidal NevusPrimary Uveal Melanoma (UM)+3 more
Memorial Sloan Kettering Cancer Center 196
Not applicableLooking for participantsNCT06643208
What this trial is testing

D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fujian Provincial Hospital 37
Early research (Phase 1)Looking for participantsNCT05791448
What this trial is testing

AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease

Who this might be right for
Advanced CholangiocarcinomaAdvanced Hepatocellular CarcinomaAdvanced Malignant Solid Neoplasm+4 more
University of Southern California 36
Not applicableStudy completedNCT04069468
What this trial is testing

Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Boston Scientific Corporation 1,247
Early research (Phase 1)Ended earlyNCT02757391
What this trial is testing

CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal Tumors

Who this might be right for
Colorectal AdenocarcinomaMetastatic CholangiocarcinomaMetastatic Colorectal Carcinoma+10 more
M.D. Anderson Cancer Center 1
Early research (Phase 1)Study completedNCT02333188
What this trial is testing

Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Adenocarcinoma of Unknown PrimaryAdult CholangiocarcinomaGallbladder Carcinoma+14 more
University of Chicago 50
Not applicableUnknownNCT02607826
What this trial is testing

Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors

Who this might be right for
CholangiocarcinomaPancreatic Ductal AdenocarcinomaColorectal Cancer+3 more
University Hospital Tuebingen 298
Not applicableLooking for participantsNCT02757859
What this trial is testing

High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery

Who this might be right for
Acinar Cell CarcinomaAmpulla of Vater AdenocarcinomaCholangiocarcinoma+5 more
Sidney Kimmel Cancer Center at Thomas Jefferson University 845
Not applicableEnrolling By InvitationNCT06474091
What this trial is testing

Liquid Biopsy MonitORing Of CholangioCarcinOma for Treatment Response and Prognostic Outcomes (MOROCCO)

Who this might be right for
Cholangiocarcinoma
Mayo Clinic 500
Testing effectiveness (Phase 2)Study completedNCT00019786
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases

Who this might be right for
Colorectal CancerIslet Cell TumorLiver Cancer+2 more
National Institutes of Health Clinical Center (CC) 67
Testing effectiveness (Phase 2)WithdrawnNCT01775280
What this trial is testing

Response of Hepatic Tumors to Radioembolization

Who this might be right for
Hepatocellular CarcinomaIntrahepatic CholangiocarcinomaLiver Metastasis
University of Zurich
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07160283
What this trial is testing

The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Cancer and Pancreatic Cancer

Who this might be right for
Biliary Tract NeoplasmsPancreatic Neoplasms
The Second Affiliated Hospital of Shandong First Medical University 96
Large-scale testing (Phase 3)Ended earlyNCT02200042
What this trial is testing

Radiation Therapy vs. Observation Following Gemcitabine and Cisplatin for Inoperable Localized Liver Cancer

Who this might be right for
Stage III Intrahepatic CholangiocarcinomaStage IVA Intrahepatic Cholangiocarcinoma
NRG Oncology 1
Not applicableStudy completedNCT02166970
What this trial is testing

Single Versus Multiple Deployment of Metallic Stents for Inoperable Malignant Hilar Biliary Obstruction

Who this might be right for
Klatskin Tumor
Soon Chun Hyang University 130
Very early researchActive Not RecruitingNCT00737399
What this trial is testing

Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)

Who this might be right for
Depression
Soul Medicine Institute 14
Not applicableUnknownNCT04637048
What this trial is testing

Observational Study on Patients With Hepatobiliary Tumors

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinomaGallbladder Cancer+3 more
Gang Chen, MD 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05451849
What this trial is testing

A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer

Who this might be right for
MesotheliomaMesotheliomas PleuralMesothelioma, Malignant+14 more
TCR2 Therapeutics 6
Load More Results